We dont believe in quick fixeswe believe in equipping you with the tools and knowledge to maintain a healthy weight for life
Ask your healthcare provider or pharmacist about their access to local health resources, such as health departments or clinics that provide lower-cost or free services in your community
A recent lawsuit has been filed against Novo Nordisk and Eli Lilly, the manufacturers of Ozempic and Mounjaro, two diabetes medications increasingly used off-label for weight loss
To our knowledge, the cases herein are the first to demonstrate potential mental health benefits of this next-generation class of drugs, as demonstrated by the GLP-1/GIP receptor agonist tirzepatide
Ozempic's active ingredient is semaglutide, described by Pulse & Remedy as a GLP-1 receptor agonist that mimics the hormone glucagon-like peptide-1 to regulate appetite, insulin secretion, and blood sugar
| Kara Kenney WRTV